Favourable Prognostic Role of High Basal Maximal Standardized Uptake Value in Follicular Lymphoma

Abstract

However, treatment guidance by iPET is not yet recommended for DLBCL in clinical practice. We aimed to assess the predictive value of iPET in progression free survival (PFS) and overall survival (OS) in DLBCL patients (pts).Methods: Single centre retrospective analysis of pts diagnosed with DLBCL from 2010 to 2019, uniformly treated with R-CHOP/R-CHOP-like protocols (6-8 cycles) and submitted to iPET assessment after 3-4 cycles of treatment. Negative iPET (iPET-) was defined by